US Broker Ratings

10x Genomics, Inc. (TXG) Investor Outlook: Navigating Mixed Analyst Ratings Amid a Promising Sector

10x Genomics, Inc. (NASDAQ: TXG), a prominent player in the healthcare sector, specifically within the health information services industry, has garnered significant attention from investors. Headquartered..

Guardian Pharmacy Services, Inc (GRDN) Stock Analysis: A Promising Healthcare Play with 9% Upside Potential

Guardian Pharmacy Services, Inc. (NASDAQ: GRDN), a key player in the healthcare sector, provides innovative pharmacy services specifically designed for long-term care facilities in the United..

NewAmsterdam Pharma (NAMS) Stock Analysis: Unveiling a 43.88% Potential Upside in the Biotech Sector

NewAmsterdam Pharma Company N.V. (NASDAQ: NAMS), headquartered in Naarden, the Netherlands, is making waves in the biotechnology sector with its ambitious pursuits in metabolic disease therapies...

Arrowhead Pharmaceuticals, Inc. (ARWR)

⚠️ No article content returned.

..

Centessa Pharmaceuticals (CNTA) Stock Analysis: A 69% Upside Potential in Biotech Innovation

Centessa Pharmaceuticals plc (NASDAQ: CNTA), a UK-based biotechnology firm, has captured investor attention with its promising pipeline and substantial potential upside of 69.42%. Positioned within the..

LeMaitre Vascular, Inc. (LMAT) Stock Analysis: Navigating a 26% Upside Potential in the Medical Devices Sector

LeMaitre Vascular, Inc. (NASDAQ: LMAT), a prominent player in the healthcare sector, specializes in medical instruments and supplies, particularly for vascular surgery. Headquartered in Burlington, Massachusetts,..

Aveanna Healthcare Holdings Inc (AVAH): Investor Outlook Reveals 29.56% Potential Upside in Healthcare Sector

Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a prominent player in the healthcare sector, stands out as a diversified home care platform company offering a range of..

AtriCure, Inc. (ATRC) Stock Analysis: Strong Buy Ratings with 29% Upside Potential

AtriCure, Inc. (NASDAQ: ATRC), a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry, has been gaining significant attention from investors...

MoonLake Immunotherapeutics (MLTX) Stock Analysis: Exploring a 30% Upside Potential in the Biotech Sector

MoonLake Immunotherapeutics (MLTX), a Swiss-based clinical-stage biotechnology company, is attracting attention in the healthcare sector with its innovative approach to treating inflammatory diseases. Despite being a..

Celldex Therapeutics (CLDX) Stock Analysis: Biotechnology Innovator with Over 100% Upside Potential

Celldex Therapeutics, Inc. (NASDAQ: CLDX), a biopharmaceutical company specializing in the development of therapeutic antibodies, is capturing the attention of investors with its significant potential upside...

Indivior PLC (INDV) Stock Analysis: A Prescription for Growth with 4.43% Upside

Indivior PLC (INDV), a notable player in the healthcare sector, has carved a niche in the specialty and generic drug manufacturing industry. With a focus on..

Travere Therapeutics, Inc. (TVTX) Stock Analysis: Exploring a 10.77% Upside Potential in the Biotech Sector

In the dynamic world of biotechnology, Travere Therapeutics, Inc. (NASDAQ: TVTX) is making a name for itself with its innovative approach to treating rare kidney and..

Azenta, Inc. (AZTA) Stock Analysis: Exploring a 19.81% Potential Upside in the Healthcare Sector

Azenta, Inc. (NASDAQ: AZTA) is an intriguing player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of $1.64..

Edgewise Therapeutics, Inc. (EWTX) Stock Analysis: Exploring a 61.93% Upside Potential in Biotech

Edgewise Therapeutics, Inc. (NASDAQ: EWTX), a biopharmaceutical company at the forefront of muscle disorder therapeutics, presents an intriguing opportunity for investors willing to navigate the volatile..

Ardent Health, Inc. (ARDT) Stock Analysis: Unveiling a Potential 52.87% Upside for Investors

Ardent Health, Inc. (NASDAQ: ARDT), a key player in the U.S. healthcare sector, is drawing investor attention due to its robust potential upside of 52.87%. Situated..

AdaptHealth Corp. (AHCO) Stock Report: Analysts See a 35% Upside Potential

AdaptHealth Corp. (NASDAQ: AHCO), a prominent player in the healthcare sector, specializes in the distribution of home medical equipment (HME) and related services across the United..

Pediatrix Medical Group, Inc. (MD) Stock Analysis: Assessing the 3.5% Potential Upside and Market Position

Pediatrix Medical Group, Inc. (NYSE: MD) is a prominent player in the healthcare sector, particularly within the medical care facilities industry. With a market capitalization of..

Recursion Pharmaceuticals, Inc. (RXRX) Investor Outlook: Uncovering a 60% Upside Potential in Biotech Innovation

Recursion Pharmaceuticals, Inc. (RXRX), a trailblazer in the biotechnology sector, has captured investor attention with its innovative approach to drug discovery and a compelling potential upside..

Pacira BioSciences, Inc. (PCRX): Analyst Ratings Suggest an 18% Upside Potential for Investors

Pacira BioSciences, Inc. (NASDAQ: PCRX), a key player in the healthcare sector specializing in non-opioid pain management solutions, is currently capturing investor attention with its promising..

Galapagos NV (GLPG) Stock Analysis: Navigating Biotech Volatility with Strategic Insights

Nestled in the heart of Europe, Galapagos NV (GLPG) operates in the fast-paced and high-stakes biotechnology sector. With a focus on innovative therapies in oncology and..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds